Novel Mutations in CYP11B1 Gene Leading to 11 beta-Hydroxylase Deficiency in Brazilian Patients


Autoria(s): SOARDI, Fernanda C.; PENACHIONI, Junia Y.; JUSTO, Giselle Z.; BACHEGA, Tania A. S. S.; INACIO, Marlene; MENDONCA, Berenice B.; CASTRO, Margaret de; MELLO, Maricilda P. de
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

Background: Deficiency of 11 beta-hydroxylase results in the impairment of the last step of cortisol synthesis. In females, the phenotype of this disorder includes different degrees of genital ambiguity and arterial hypertension. Mutations in the CYP11B1 gene are responsible for this disease. Objective: The objective of the study was to screen the CYP11B1 gene for mutations in two unrelated Brazilian females with congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Design: The coding and intron-exon junction regions of CYP11B1 were totally sequenced. A putative splice mutation was further investigated by minigene transcription. Results: We report two novel CYP11B1 mutations in these Brazilian patients. An Arabian Lebanese descendent female was found to be homozygous for a cytosine insertion at the beginning of exon 8, changing the 404 arginine to proline. It alters the open reading frame, creating a putative truncated protein at 421 residue, which eliminates the domain necessary for the association of heme prosthetic group. A severely virilized female was homozygous for the g. 2791G>A transition in the last position of exon 4. This nucleotide is also part of 5` intron 4 donor splice site consensus sequence. Minigene experiments demonstrated that g. 2791G>A activated an alternative splice site within exon 4, leading to a 45-bp deletion in the transcript. The putative translation of such modified mRNA indicates a truncated protein at residue 280. Conclusions: We describe two novel mutations, g. 4671_4672insC and g. 2791G>A, that drastically affects normal protein structure. These mutations abolish normal enzyme activity, leading to a severe phenotype of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. (J Clin Endocrinol Metab 94: 3481-3485, 2009)

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[97/14076-4]

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[05/00981-5]

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[98/16309-9]

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[03/01785-0]

Coordenacao de Aperfeiçoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brasil

Identificador

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, v.94, n.9, p.3481-3485, 2009

0021-972X

http://producao.usp.br/handle/BDPI/23945

10.1210/jc.2008-2521

http://dx.doi.org/10.1210/jc.2008-2521

Idioma(s)

eng

Publicador

ENDOCRINE SOC

Relação

Journal of Clinical Endocrinology & Metabolism

Direitos

restrictedAccess

Copyright ENDOCRINE SOC

Palavras-Chave #CONGENITAL ADRENAL-HYPERPLASIA #21-HYDROXYLASE DEFICIENCY #HYPERTENSION #PREDICT #SITES #Endocrinology & Metabolism
Tipo

article

original article

publishedVersion